Introduction
============

Colorectal cancer (CRC) is the third leading cause of cancer mortality in the world ([@B21]), and is influenced by heredity, diet, lifestyle, gut microbiota, and other factors ([@B6]; [@B42]). The human intestinal tract is a nutrient-rich environment housing the largest microbial communities ([@B50]). The gut microbiota has garnered great attentions because of its important role in influencing CRC risk by metabolites and immunity in the host ([@B35]). For example, some bacteria producing hydrogen sulfide, acetaldehyde and secondary bile acids can contribute to the risk of CRC ([@B20]; [@B5]). Simultaneously, some bacteria, including the orders *Clostridiales, Lactobacillales, Bifidobacteriales*, and *Actinomycetales* ([@B11]), may reduce CRC risk by producing butyrate and conjugated linoleic acids ([@B37]). Therefore, understanding the role of gut microbiota contributes to improving CRC patients' care.

Human gut microbiota is considered as an essential "organ," which plays a key role in providing nourishment, regulating epithelial development, and modulating immunity ([@B12]). In recent years, many researchers have attempted to understand the differences in gut microbiota by comparing the microbial community structures of CRC patients and healthy individuals and identify reliable microbial markers for CRC precursors ([@B49]). Previously, it has been reported that the abundances of *Enterococcus faecalis* ([@B3]) and *Desulfovibrio* sp. ([@B36]) were observably higher in CRC patients than that in healthy individuals, whereas *Bacteroides/Prevotella* levels were significantly lower ([@B40]). Differences were also observed in the overall structure of gut microbiota between CRC patients and healthy individuals ([@B40]). Despite of advances in understanding the connections between gut microbiota and CRC, little is known about how surgery resection influences the gut microbiota. Current studies have indicated that many patients who undergo treatment may experience recurrence and even die within several years ([@B34]). Therefore, identifying valid methods to evaluate post-surgery patients' condition is vital in reducing mortality and healthcare costs.

Gut microbiota is strongly influenced by the surgical removal of lesions, and influences the intestinal healing, particularly with respect to anastomotic tissues in colorectal surgery ([@B1]). In this pilot study, we analyzed fecal samples of CRC patients and healthy individuals by 16S rRNA gene sequencing and real-time quantitative PCR. First, we used the classical community analysis and statistical tests to compare the gut microbial community structure and composition between CRC patients and healthy individuals. Next, we generated functional discrepancy prediction and molecular ecological network to further examine the differences among them. Finally, we discussed the correlates of gut microbiota and clinical variables for the probabilities to assess whether gut microbiota played a key role in identifying the condition for post-surgery CRC patients.

Materials and Methods {#s1}
=====================

Study Design
------------

Our pilot study subjects comprised 10 CRC patients and 11 healthy individuals (Supplementary Figure [S1](#SM10){ref-type="supplementary-material"}). The CRC patients, aged 34--63 years, were from the affiliated hospital of Qingdao University (Qingdao, China, Table [1](#T1){ref-type="table"} and Supplementary Tables [S1](#SM1){ref-type="supplementary-material"}, [S2](#SM2){ref-type="supplementary-material"}). The pilot study selected from untreated CRC patients and excluded those (*N* = 6) who had previously undergone surgery, chemotherapy, radiation, or targeted therapies before samples collection. Fecal samples from these pre-surgery CRC patients were collected prior to a colonoscopy ([@B31]). The lesion location of all the selected CRC patients was in rectum. These CRC patients were treated with palliative surgery or radical surgery, such as Dixon, Miles and Hartmann (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}). Following up samples were obtained in approximately 1 month after the surgery. The healthy individuals, aged 49--64 years, were selected as controls (Table [1](#T1){ref-type="table"} and Supplementary Table [S2](#SM2){ref-type="supplementary-material"}). During a routine physical examination, none had any recorded antibiotics usage or gastrointestinal tract disorders within 3 months preceding the sample collection. All of the participants have been local residents of Qingdao city. This pilot study was approved by the Affiliated Hospital of Qingdao University Institutional Review Board, and all pilot study participants signed the informed consent before participation. All fecal samples were collected within 3 h after defecation in the morning. The collected samples from the healthy individuals, pre-surgery CRC patients and post-surgery CRC patients were named by H, A0, and A1, respectively. Fresh fecal samples were put into 5 ml tubes and immediately stored at -80°C until the day of analysis.

###### 

Baseline characteristics in healthy individuals and colorectal cancer patients.

  Variable                  Healthy individuals   Colorectal cancer patients   *P*-value
  ------------------------- --------------------- ---------------------------- -----------
  Number                    11                    10                           /
  Age, year, median (IQR)   60 (49--64)           59 (34--63)                  0.386
  Sex (Female/Male), n      9/2                   4/6                          0.051
  BMI, median (IQR)         24.1 (21.4--28.2)     25.5 (19.5--31.8)            0.211
  Tumor location            /                     Rectum                       /

DNA Extraction, Purification, Sequencing and Data Processing
------------------------------------------------------------

Extraction of bacterial DNA was performed from fecal samples using a QIAamp Fast DNA Stool Mini Kit as previously reported ([@B45]). The freshly extracted DNA was purified by 0.5% melting point agarose gel followed by phenolchloroform-butanol extraction. The V3-V4 region of the bacterial 16S rRNA gene from each DNA sample was amplified using the bacterial universal primers (forward primer: 5′-ACTCCTACGGGRSGCAGCAG-3′; reverse primer: 5′-GGACTACVVGGGTATCTAATC-3′). PCR amplification was performed in a 30 μl reaction, containing 15 μl of 2 × KAPA HiFi Hotstart ReadyMix, 1 μl of each primer (forward and reverse primer), 10 ng of template DNA, and the remaining volume of ddH~2~O. The reaction mixtures were denatured at 95°C for 1 min; followed by 12 cycles of 98°C for 15 s, 72°C for 10 s, 94°C for 20 s, 65°C for 10 s and 72°C for 10 s; then 11 cycles of 94°C for 20 s, 58°C for 30 s, 72°C for 30 s; and a final extension at 72°C for 150 s. The PCR amplification products were purified with an AxyPrep DNA Gel Extraction Kit (Axygen, United States), eluted in 30 μl water, and aliquoted into three PCR tubes. DNA quality and quantity were assessed by the ratios of 260/280 nm and 260/230 nm, and final DNA contents were quantified with a Qubit^®^ dsDNA HS Assay Kit (Invitrogen, United States). Finally, we used bacterial DNA amplicons from each fecal sample for 2 × 250 bp paired-end sequencing based on the Illumina Hiseq 2500.

Raw sequences were separated into samples by barcodes using the Galaxy Illumina sequencing pipeline^[1](#fn01){ref-type="fn"}^. Adapters, ambiguous and low-quality reads ("N") were trimmed by Btrim ([@B23]). Forward and reverse reads were incorporated into a whole sequence by FLASH ([@B26]). After quality control of the raw data, the clean reads were clustered into operational taxonomic units (OTUs) at 97% similarity level by using UCLUST ([@B13]). Each OTU was considered to represent a species ([@B9]). Rarefaction analysis was performed using the original detected OTUs (Supplementary Figure [S2](#SM10){ref-type="supplementary-material"}). The ribosomal database project (RDP) classifier was used to determine the taxonomic assignment ([@B43]). Random resampling was conducted on 48,360 sequences per fecal sample.

Real-Time Quantitative PCR
--------------------------

Three specific primers were used for real-time quantitative PCR (qPCR), including 16S rRNA universal primer for bacteria, primer for *Fusobacterium nucleatum* ([@B7]), primer for *Klebsiella pneumonia* ([@B41]) (Supplementary Table [S3](#SM3){ref-type="supplementary-material"}). The primers were synthesized at Shanghai Sangon Company (China). The PCR program was as follows: 95°C for 3 min; 35 cycles of 94°C for 30 s, 57°C for 30 s, and 72°C for 30 s; 72°C for 8 min. The PCR products were purified with gel extraction kit (Sangon SK8131), quantified using Micro-spectrophotometer SMA4000 (Merinton), and used to construct standard curves. The copy number of PCR products was calculated based on the formula: Copy number/μL = 6.02 × 10^14^ × C/(*M* × *W*). The C (unit, ng/μL) represents the concentration of PCR products, *M* (unit, bp) represents the length of PCR products, and *W* (660 Da/bp) represents the constant. The PCR products were diluted from 10^7^ to 10^10^ copies/μL and amplified to construct standard curves. The real-time qPCR was run with LightCycler480 II (Roche, German). The reaction mixture contained 5 μL SybrGreen qPCR Master Mix (Roche, German), 1 μL of template DNA, and 0.2 μL forward/reverse primer (10 μM), and ddH2O was added to reach a total volume of 10 μL. The real-time qPCR program was as follows: 95°C for 3 min; 45 cycles of 95°C for 15 s, 57°C for 20 s, and 72°C for 30 s. The melting curves for the amplicons were measured while monitoring fluorescence. The amplification efficiencies of three primers were between 80 and 110%, and the melting curves all showed a single peak (Supplementary Figure [S3](#SM10){ref-type="supplementary-material"}), indicating that the results were credible. The copies of each sample based on 16S rRNA universal primer were considered as the bacterial biomass per gram. The following formula was used to calculate the relative abundance: Relative abundance = Ci/C0 × 100%, where Ci represents the copies of the species and C0 represents the bacterial biomass ([@B46]).

Network Analysis
----------------

Gut microbial ecological networks were constructed and analyzed by random matrix theory (RMT) methods by the online MENA pipeline^[2](#fn02){ref-type="fn"}^. OTUs detected in less than 70% from each group were removed to ensure reliable correlations. For comparisons with different networks, the same cutoff of 0.77 was applied to construct ecological networks for gut microbial communities. Each ecological network was separated into modules by the fast greedy modularity optimization to characterize the modularity property. Furthermore, a network developed from OTU abundance data represented the ecological co-occurrence (links) of different OTU markers (nodes) in a microbial community, and different nodes played distinct roles ([@B19]).

Statistical Analysis
--------------------

The common OTUs mean that the OTUs present in three groups (A1, A0 and H). Principal coordinate analysis (PCoA) was used to identify overall gut microbial composition between CRC patients and healthy individuals based on Bray-Curtis dissimilarity index. Principal components analysis (PCA) was used to determine the changes of KEGG pathways between CRC patients and healthy individuals. Alpha diversity was calculated using the observed species (richness), phylogenetic diversity, Shannon index and Simpson index. The significant differences referred to the multiple response permutation procedure (MRPP) algorithms and analysis of similarity (Anosim). Significant *P*-values associated with microbial clades and functions were identified by Linear Discriminant Analysis with Effect Size (LEfSe). Characteristics with an LDA score cut-off of 2.0 were considered as being different. Community analysis and differential abundance of OTUs were performed using the STAMP 2.0.8 ([@B33]). According to the Kyoto Encyclopedia of Genes and Genomes (KEGG) orthology, functional profiling of microbial communities was predicted using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) ([@B25]). Gut microbial metabolic and other pathway differences were predicted by the correlations between the PICRUSt-generated functional profiles and STAMP-generated genus level bacterial abundance. Mantel test was used to evaluate the linkages between gut microbial structure and environmental attributes. The R software package (v3.4.1) was used for all statistical analysis, except for two-tailed unpaired *t*-tests by Microsoft Excel 2010, and Analysis of variance (ANOVA) and Pearson correlation by IBM SPSS statistic 19.0 to determine the significance of the differences and the clinical correlates.

Results
=======

Taxonomic Composition and Diversity of Gut Microbiota
-----------------------------------------------------

A total of 1,819,210 quality-filtered 16S rRNA gene sequences were acquired from 31 samples, with an average of 58,684 ± 2602 reads per sample (Supplementary Table [S4](#SM4){ref-type="supplementary-material"}). A total of 648 OTUs were generated at the 97% similarity level, with an average of 189 ± 60 OTUs per sample (Supplementary Table [S4](#SM4){ref-type="supplementary-material"}). We compared the microbial alpha diversity (richness, phylogenetic diversity, Shannon diversity and Simpson diversity) between CRC patients and healthy individuals (Table [2](#T2){ref-type="table"}). The results demonstrated that the Shannon diversity and Simpson diversity were significantly decreased in A1 compared with the A0 and H (*P* \< 0.05, Table [2](#T2){ref-type="table"}). However, no statistically significant differences were identified in the richness and phylogenetic diversity for CRC patients and healthy individuals (*P* \> 0.05, Table [2](#T2){ref-type="table"}). The dissimilarity tests showed that A1 was significantly different from A0 and H based on the multiple response permutation procedure (MRPP) algorithms and analysis of similarity (ANOSIM) (*P* \< 0.05, Supplementary Table [S5](#SM5){ref-type="supplementary-material"}). PCoA based on Bray-Curtis dissimilarity index revealed overall gut microbial composition in CRC patients was well separated from each other, but partly overlapping with healthy individuals (Figure [1](#F1){ref-type="fig"}). Furthermore, A1 presented a more scattered distribution and had a distance from the A0 and H (Figure [1](#F1){ref-type="fig"}). Therefore, A1 had significantly different community structure with A0 and H.

###### 

Comparison of alpha diversity indices of gut microbiota between the healthy volunteers (H) and CRC patients before and after surgery (A0 and A1).

  Group   Richness      Phylogenetic diversity   Shannon diversity   Simpson diversity
  ------- ------------- ------------------------ ------------------- -------------------
  A0      (199 ± 56)a   (15.10 ± 4.00)a          (4.63 ± 0.91)a      (0.90 ± 0.08)a
  A1      (166 ± 77)a   (14.14 ± 5.25)a          (3.40 ± 1.27)b      (0.76 ± 0.23)b
  H       (187 ± 41)a   (14.31 ± 2.44)a          (4.34 ± 0.91)a      (0.88 ± 0.08)a

Values are shown as mean ± standard deviation. Richness means the detected gene/sequence numbers. Significant differences among different groups are indicated by alphabetic letters,

P

\< 0.05. The 'a' means there are no significance differences among groups. The 'b' means the group is significantly different from other two groups.

![Principal coordinates analysis (PCoA) ordination (operational taxonomic units = 97% 16S rRNA sequence similarity) showing distinctly different microbial composition between CRC patients and healthy individuals based on the Bray-Curtis dissimilarity matrix.](fmicb-09-02777-g001){#F1}

Taxonomy-Based Comparisons of the Gut Microbiota
------------------------------------------------

The gut microbial taxa and their relative abundance were significantly different among H, A0, and A1. At the phylum level, H was mainly characterized by *Firmicutes* and *Bacteroidetes*, whereas A0 and A1 had a very complicated community composition, especially for A1 (Supplementary Figure [S4](#SM10){ref-type="supplementary-material"}). Compared with H, the relative abundance of *Proteobacteria* was significantly increased by 12.90%, and *Bacteroidetes* was significantly decreased by 23.06% in A1 (*P* \< 0.05, Supplementary Table [S6](#SM6){ref-type="supplementary-material"}). At the genus level, the members of *Faecalibacterium, Roseburia, Ruminococcus*, and *Lachnospiracea_incertae_sedis* were significantly lower in A1 than those in H (*P* \< 0.05, Supplementary Figure [S5](#SM10){ref-type="supplementary-material"} and Supplementary Table [S7](#SM7){ref-type="supplementary-material"}). To identify gut microbial responses associated with surgery at the taxonomical level, we determined microbial clade differences using LEfSe analysis (Figure [2](#F2){ref-type="fig"}). At the phylum level, higher proportions of *Proteobacteria* were observed in A1 than that in A0 and H (Figure [2A](#F2){ref-type="fig"}). At the genus level, greater proportions of *Klebsiella* were detected in A1 than that in A0 (Supplementary Figure [S6](#SM10){ref-type="supplementary-material"}). The genus *Fusobacteria* was significantly enriched in A0 than that in A1 and H (Figure [2B](#F2){ref-type="fig"}). The members of *Clostridium XlVa, Fusobacterium, Parvimonas*, and *Peptostreptococcus* were more abundant on A0 than that on A1 and H (Figure [2A](#F2){ref-type="fig"}).

![Microbial biomarkers among healthy volunteers (H) and CRC patients (A0 and A1). **(A)** LEfSe analysis shows differentially abundant taxa as biomarkers using Kruskal--Wallis test (*P* \< 0.05) with LDA score \> 2.0. **(B)** Cladogram representation of the differentially abundant taxa. The root of the cladogram represents the domain bacteria. The size of each node represents their relative abundance. No significantly different taxa are labeled by yellow. Significant different taxa are labeled by following the color of each group.](fmicb-09-02777-g002){#F2}

Sequencing data suggested that gut microbiota made changes in response to surgery, and we further used real-time qPCR to help validate changes observed and detected with 16S sequencing data. We selected *Fusobacterium nucleatum* and *Klebsiella pneumoniae* to examine the variations, which frequently present in CRC patients (Supplementary Figure [S7](#SM10){ref-type="supplementary-material"}). The results showed that the relative abundance of *Fusobacterium nucleatum* in A0 was significantly higher than that in H (*P* \< 0.05). However, the relative abundance of *Klebsiella pneumoniae* was not significantly changed. In addition, individual differences were evident showed in Supplementary Figure [S8](#SM10){ref-type="supplementary-material"}. Notably, the relative abundance of *Fusobacterium* increased markedly in 8/10 patients of A0 compared with A1. The members of *Klebsiella* were distinctly higher in 9/10 patients of A1 than that in A0.

Functional and Metabolic Discrepancy of the Gut Microbiota
----------------------------------------------------------

Further studies were required to understand the dynamics of gut microbiota following surgical treatment to evaluate the role of microbiota. The PCA of KEGG pathways indicated that A1 was notably different from A0 and H, which had a more scattered distribution based on the STAMP analysis (Figure [3A](#F3){ref-type="fig"}). In terms of KEGG pathways (L2, Figure [3B](#F3){ref-type="fig"}), the functions of 'replication and repair,' 'folding, sorting and degradation,' and 'cell growth and death,' which belong to the first level 'Genetic information processing' and 'Cellular processes,' respectively, were significantly enriched in A0 (*P* \< 0.05) compared with H and A1 based on the LEfSe analysis. The results indicated that gut microbiota in pre-surgery patients was enriched in more conservative housekeeping functions. The 'infectious diseases,' 'xenobiotics biodegradation and metabolism,' 'metabolism of other amino acids,' 'neurodegenerative diseases,' and 'metabolism' were significant function hallmarks of gut microbiota in A1. Furthermore, we found that the genus *Klebsiella* in A1 was significantly and closely associated with infectious diseases, such as bacterial invasion of epithelial cells and *Staphylococcus aureus* infection (*P* \< 0.05, Figure [4](#F4){ref-type="fig"}).

![Functional and metabolic discrepancy of the gut microbiota between CRC patients and healthy individuals. **(A)** Principal component analysis (PCA) plot of the KEGG pathway (L2) shows that the post-surgery CRC patients were noticeably different from the pre-surgery CRC patients and healthy individuals based on the STAMP analysis. Characteristics with an LDA score cut-off of 2.0 were considered as being different. The LDA scores (log10) \> 2 are listed; **(B)** Discriminatory functional pathways (KEGG L2) shows the significantly different between CRC patients and healthy individuals based on the LDA score using the LEfSe analysis.](fmicb-09-02777-g003){#F3}

![Gut microbial metabolic and other pathway differences in pre-surgery CRC patients (A0) and post-surgery CRC patients (A1). Correlations between the PICRUSt-generated functional profiles and STAMP-generated genus level bacterial abundance are calculated and plotted.](fmicb-09-02777-g004){#F4}

Modularity Analysis in Gut Microbiota
-------------------------------------

Microbes rarely live in isolation, but instead interact in complex ecological networks. To identify the assemblages that potentially interact within the intestinal tract, we focused on representative networks from CRC patients and healthy individuals. We selected more than five nodes to construct the modules and visualized the phylogeny for modules with at least two kinds of phyla (Figure [5](#F5){ref-type="fig"}). Overall, OTU tended to co-occur (positive correlations, gray lines) rather than co-exclude (negative correlations, pink lines). However, there were more negative correlations between gut microbes in A0 than that in A1 and H (Figure [5](#F5){ref-type="fig"}). The modules in A1 became smaller and less connected, which had fewer nodes and links (35, 37) than that in A0 (60, 113) and in H (91, 231). Furthermore, the kinds of phylum in each module were only two in A1, which were less than that in A0 and H.

![Highly connected modules of gut microbial networks within CRC patients before and after surgery (A0, A1) and healthy individuals (H). The colors of nodes indicate different major phyla; pie charts represent the composition of modules with ≥ 2 phyla. A pink link indicates negative correlations between two individual nodes, whereas a gray link indicates positive correlations. The percentage in parentheses indicates the ratio of positive correlations.](fmicb-09-02777-g005){#F5}

Correlates of Gut Microbiota and Clinical Variables
---------------------------------------------------

Based on the mantel test, we explored the clinical correlates of gut microbiota and patients age, sex, BMI, and bowel treatment. The results showed that the whole gut microbiota and key phyla had no significant correlations with these clinical variables (Supplementary Table [S8](#SM8){ref-type="supplementary-material"}). Then, we analyzed the histopathological correlates of gut microbiota and tumor stage, grade of tumor differentiation, lymphatic invasion, perineural invasion, number of metastasis lymph nodes and tumor markers (CEA and CA199) (Supplementary Table [S9](#SM9){ref-type="supplementary-material"}). We found that the *Fusobacterium* (*Fusobacteria, Fusobacteriia, Fusobacteriales, Fusobacteriaceae*) in A0 and *Klebsiella* (*Proteobacteria, Gammaproteobacteria, Enterobacteriales, Enterobacteriaceae*) in A1 were significantly correlated with lymphatic invasion (*P* \< 0.05). The *Fusobacterium* (*Fusobacteria, Fusobacteriia, Fusobacteriales, Fusobacteriaceae*) in A0 was significantly correlated with CA199 (*P* \< 0.05).

Discussion
==========

The gut microbiota interacts extensively with the host by the co-metabolism of substrates and metabolic exchanges to maintain a healthy status and normal functions of the body ([@B30]). Previous studies have highlighted the significance of gut microbiota in the progression of intestinal diseases such as Crohn's disease, ulcerative colitis ([@B44]), celiac disease in children ([@B29]), allergic inflammation in infants ([@B22]), and CRC ([@B1]). In this pilot study, we focused on exploring the feedback of gut microbiota of CRC patients in response to the surgical removal of lesions.

The gut microbial community composition and diversity in post-surgery CRC patients significantly differ from that in pre-surgery CRC patients and healthy individuals (*P* \< 0.05, Figure [1](#F1){ref-type="fig"}, Table [2](#T2){ref-type="table"}, and Supplementary Table [S5](#SM5){ref-type="supplementary-material"}). However, the gut microbial alpha diversity in A0 was not significantly different from that in H (Table [2](#T2){ref-type="table"}). The findings may be explained by previous report that the fecal microbiota only partially reflected mucosal microbiota in CRC ([@B14]). The alpha diversity in A1 was significantly lower than that in H (*P* \< 0.05). High diversity is always linked to health and temporal stability ([@B16]). Conversely, a relative lack of diversity is often observed in the gut microbiota of CRC patients ([@B17]). Antibiotics use causes a dramatic reduction in the diversity of gut microbiota ([@B10]), which was similar to our results that the gut microbial diversity was significantly decreased in post-surgery CRC patients, potentially weakening the community's ability to resist pathogens.

[@B15] had previously confirmed that the microbiota of CRC patients differed from that of controls ([@B15]), and similar results had been found in our study that gut microbial taxa and their relative abundance of CRC patients, especially for post-surgery CRC patients, significantly differed from that of healthy individuals (*P* \< 0.05). Generally, the gut microbiota in healthy individuals is dominated by the phyla *Firmicutes* and *Bacteroidetes* ([@B8]), whereas *Proteobacteria, Actinobacteria, Verrucomicrobia*, and *Fusobacteria* are less abundant ([@B2]). The relative abundance of phylum *Proteobacteria* was significantly higher in A1 than that in A0 and H (*P* \< 0.05, Figure [2A](#F2){ref-type="fig"} and Supplementary Table [S6](#SM6){ref-type="supplementary-material"}). Imbalanced gut microbiota often results from a sustained increase in *Proteobacteria*, and human gut microbiota normally contains a minor proportion of this phylum ([@B39]). A bloom of *Proteobacteria* in the gut often reflects an unstable structure of the gut microbial community, which was often observed in the disease states ([@B28]). *Proteobacteria* was often associated with dysbiosis and was a potential diagnostic criterion for disease ([@B39]). The relative abundance of phylum *Fusobacteria* was significantly increased in A0 than that in A1 and H (*P* \< 0.05, Figure [2B](#F2){ref-type="fig"}). At the genus level, *Klebsiella* played more significantly key roles in A1 than that in A0 (*P* \< 0.05, Supplementary Figure [S6](#SM10){ref-type="supplementary-material"}). However, the relative abundance of *Klebsiella pneumoniae* was not significantly changed based on the real-time qPCR (Supplementary Figure [S7](#SM10){ref-type="supplementary-material"}). The reasons were probably ascribed to the small sample size, followed by the low abundance in sample itself, DNA degradation of human feces, the sensitivity and specificity of primer, reaction condition of qPCR. In addition, *Clostridium XlVa, Parvimonas, Peptostreptococcus*, and *Fusobacterium* played significantly important roles in A0 (*P* \< 0.05, Figure [2A](#F2){ref-type="fig"}). *Parvimonas* was frequently and significantly increased in stools from CRC patients ([@B38]). *Peptostreptococcus* played a key role in the dysbiosis of mucosa-associated microbiota in CRC patients ([@B38]). It was reported that *Fusobacterium* species led the development of CRC ([@B24]). The qPCR results also showed that *Fusobacterium nucleatum* in A0 was significantly higher than that in H (*P* \< 0.05, Supplementary Figure [S7](#SM10){ref-type="supplementary-material"}). *Fusobacterium nucleatum* infection is prevalent in human CRC ([@B7]). Furthermore, we found that *Fusobacterium* (*Fusobacteria, Fusobacteriia, Fusobacteriales, Fusobacteriaceae*) in A0 was significantly correlated with lymphatic invasion and tumor marker CA199 (*P* \< 0.05, Supplementary Table [S9](#SM9){ref-type="supplementary-material"}), similar to [@B7] results that indicated that high relative abundance of *Fusobacterium* was more likely to have regional lymph node metastases. Therefore, gut microbiota from fecal samples was increasingly possible to be considered as potential diagnostic biomarkers of dysbiosis for CRC patients ([@B48]).

Potential function and metabolism of gut microbiota in CRC patients were greatly changed in response to the surgery. Although great differences were observed in the taxonomic composition of gut microbiota in different individuals, the metabolic pathways are considerably more consistent across people ([@B8]). A healthy microbiota may contain specific microbial combinations, metabolic modules, and regulatory pathways that together maintain a stable host-associated ecology ([@B27]). The housekeeping functions are necessary for all microbial life, such as 'replication and repair' and 'cell growth and death' ([@B8]). Our results demonstrated that the housekeeping functions were significantly associated with gut microbiota in A0, whereas the gut microbiota in A1 was more closely involved with the functions of infectious diseases and xenobiotics biodegradation and metabolism (Figure [3](#F3){ref-type="fig"}). The *Klebsiella* in A1 was determined to be closely associated with infectious diseases (Figure [4](#F4){ref-type="fig"}). *Klebsiella* is an opportunistic pathogen routinely found in human gut that causes diarrhea, pneumonia, and bloodstream infections ([@B47]). It was reported that overgrowth of *Klebsiella* often foreshadowed gut flora dysbiosis ([@B18]) and markedly increased the rates of treatment failure and death ([@B47]). Furthermore, *Klebsiella* (*Proteobacteria, Gammaproteobacteria, Enterobacteriales, Enterobacteriaceae*) in A1 was significantly correlated with lymphatic invasion (*P* \< 0.05, Supplementary Table [S9](#SM9){ref-type="supplementary-material"}). Therefore, the gut microbiota in post-surgery CRC patients maybe presented a weaker robustness when random and specific perturbations influence its functional stability.

Molecular ecological networks of gut microbiota in CRC patients were also greatly changed in response to the surgery. In network biology, a group of microbial species strongly interacting with one another constructs a module, which may reflect physical contact, divergent selection, functional association, and/or the phylogenetic clustering of closely related species ([@B32]). Considering the characteristic of a smaller and looser network module in A1 (Figure [5](#F5){ref-type="fig"}), it implied that A1 had a weaker coupling between gut microbes than A0 and H. This could partially be explained by some sharply growing pathogenic bacterium, such as the phylum *Proteobacteria*, influencing the microbial community structure (Figure [2](#F2){ref-type="fig"} and Supplementary Table [S6](#SM6){ref-type="supplementary-material"}). Therefore, the gut microbiota in post-surgery patients probably had a higher sensitivity in response to external changes.

The age, sex, BMI, bowel treatment and diet were considered as the important influencing factors in changing the gut microbiota of CRC patients. However, we found that there were no significant correlations between these factors (age, sex, BMI, and bowel treatment) and gut microbiota based on the mantel test (Supplementary Table [S8](#SM8){ref-type="supplementary-material"}). Comprehensive information on microbial species across a great number of samples is essential in identifying the changes among microbial communities ([@B4]). Sample sets should ideally be ample to achieve sufficient variability ([@B4]). However, the number of patients in the treatment group was relatively small and individual differences were evident (Supplementary Figure [S8](#SM10){ref-type="supplementary-material"}). Therefore, there was not statistical power to adequately examine these relationships between these factors (age, sex, BMI, and bowel treatment) and gut microbiota. Therefore, we could not scale the results to all the situations with only a few samples. In addition, samples from the post-surgery patients were also influenced by the colonoscopy. More attentions should be paid on these correlative factors in the future. Yet, this pilot study would provide better understanding of the responses of gut microbiota to the surgical removal of lesions for CRC patients (Supplementary Figure [S9](#SM10){ref-type="supplementary-material"}). The gut microbiota probably plays a key role in identifying the condition for post-surgery CRC patients. Additional sampling efforts, colonoscopy effects, and diet records combined with clinical follow-up are required to further obtain unique insight into gut microbial changes in post-surgery CRC patients to predict disease states and develop therapies to correct dysbiosis.

Conclusion
==========

In summary, this pilot study explored the changes of gut microbiota in CRC patients following the surgery. The gut microbial taxonomic compositions in post-surgery CRC patients were significantly different from those in pre-surgery CRC patients and healthy individuals. The gut microbiota in post-surgery CRC patients had a significantly lower alpha diversity and a looser ecological interaction network. Most post-surgery CRC patients had more abundances of *Klebsiella*. The *Klebsiella* in post-surgery CRC patients was significantly associated with lymphatic invasion. These results indicated that gut microbiota was probably considered to be the valuable biomarkers in evaluating the condition of post-surgery CRC patients. More attentions should be paid to advance our understanding of the role of gut microbiota in recovering the intestinal health of post-surgery CRC patients.
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